TARGET
saveTYK2
Tyrosine kinase 2; autoimmune target.
also known as: tyrosine kinase 2
drugs
0
catalysts
0
news
90
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Roivant, the 'inveterate drug hunters', enters commercial era with Lisrayabiospace · 4d ago
- 6 immunology targets to sustain a mammoth I&I marketbiospace · 11d ago
- Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCarefiercebiotech · 15d ago
- Takeda’s long-term R&D head announces exit after major pipeline reorganizationbiospace · 28d ago
- Takeda’s long-serving R&D chief Andy Plump to retire in wake of pipeline successesfiercebiotech · 29d ago
- Schrödinger births new immunology and inflammation biotech, Tectora Therapeuticsfiercebiotech · 1mo ago
- This week in charts: China deals, stock flatlines and Lilly’s M&A spreebiopharma dive · 1mo ago
- Alumis’ TYK2 drug fails in key lupus studybiopharma dive · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that